Baird Medical Investment Holdings Limited(BDMD)

Medical - Devices · Guangzhou, GD

$0.74-0.01 (-1.09%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

Baird Medical Investment Holdings (BDMD) EV/EBITDA: History & Chart | TGMCharts

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T13:30:42.700Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:30:42.700Z.

Quote observation: 2026-10-06T13:30:01.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 30,812,397
Total debt · period ending 2026-06-30: 14,223,073
Cash · period ending 2026-06-30: 289,083
TTM operating EBITDA · period ending 2026-06-30: N/A

FMP input reference: 3c83d1468e5e3921618bd37e367f41e2e7287b0e28e44d51d30477b87a45d5ec

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

BDMD EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

BDMD Competitors' EV/EBITDA Ratio

BDMD

Baird Medical Investment Holdings Limited

Current

Market Cap

$30.81M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRVO

CervoMed Inc.

vs BDMD

Market Cap

$31.11M

EV/EBITDA Ratio

N/A

TTM Avg

0.36x

3Y Avg

0.82x

5Y Avg

0.82x

CNTX

Context Therapeutics Inc.

vs BDMD

Market Cap

$31.14M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BYSI

BeyondSpring Inc.

vs BDMD

Market Cap

$31.35M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EUDA

EUDA Health Holdings Limited

vs BDMD

Market Cap

$32.55M

EV/EBITDA Ratio

N/A

TTM Avg

10986.66x

3Y Avg

10986.66x

5Y Avg

10986.66x

ATYR

aTyr Pharma, Inc.

vs BDMD

Market Cap

$28.43M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRCE

Grace Therapeutics, Inc.

vs BDMD

Market Cap

$33.52M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALGS

Aligos Therapeutics, Inc.

vs BDMD

Market Cap

$33.79M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRDX

GridAI Technologies Corp.

vs BDMD

Market Cap

$27.31M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BEAT

HeartBeam, Inc.

vs BDMD

Market Cap

$34.65M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Baird Medical Investment Holdings Limited (BDMD)	$30.81M	N/A	N/A	N/A	N/A
CervoMed Inc. (CRVO)vs ›	$31.11M	N/A	0.36x	0.82x	0.82x
Context Therapeutics Inc. (CNTX)vs ›	$31.14M	N/A	N/A	N/A	N/A
BeyondSpring Inc. (BYSI)vs ›	$31.35M	N/A	N/A	N/A	N/A
EUDA Health Holdings Limited (EUDA)vs ›	$32.55M	N/A	10986.66x	10986.66x	10986.66x
aTyr Pharma, Inc. (ATYR)vs ›	$28.43M	N/A	N/A	N/A	N/A
Grace Therapeutics, Inc. (GRCE)vs ›	$33.52M	N/A	N/A	N/A	N/A
Aligos Therapeutics, Inc. (ALGS)vs ›	$33.79M	N/A	N/A	N/A	N/A
GridAI Technologies Corp. (GRDX)vs ›	$27.31M	N/A	N/A	N/A	N/A
HeartBeam, Inc. (BEAT)vs ›	$34.65M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics